What is Hyperreflexia?
Hyperreflexia is an exaggerated reflex response characterized by overactive or overresponsive deep tendon reflexes, often indicating upper motor neuron dysfunction or, in specific contexts, spinal cord pathology or drug-induced serotonin excess.
Clinical Definition and Mechanism
Hyperreflexia represents abnormally brisk deep tendon reflexes that occur when the normal inhibitory control of reflexes is disrupted. The reflex arc itself remains intact, but the modulating influence from higher centers is impaired or altered.
Key Clinical Contexts
Neurological Conditions
In hepatic encephalopathy, hyperreflexia appears as part of motor system abnormalities in noncomatose patients, alongside hypertonia and positive Babinski signs 1. This occurs in the context of chronic liver disease and represents pyramidal tract involvement.
In hepatic myelopathy, a specific pattern emerges with progressive spasticity and weakness of lower limbs accompanied by hyperreflexia, with relatively mild mental alterations. This condition is related to marked, long-standing porto-caval shunting and notably does not respond to standard ammonia-lowering therapy 1.
Drug-Induced Hyperreflexia (Serotonin Syndrome)
Hyperreflexia is highly diagnostic for serotonin syndrome when occurring with serotonergic drug use 2. In this context, it appears as part of the neuromuscular abnormalities triad:
- Mental status changes (confusion, agitation, anxiety)
- Autonomic hyperactivity (tachycardia, hypertension, diaphoresis, hyperthermia, tachypnea)
- Neuromuscular abnormalities (tremor, clonus, hyperreflexia, muscle rigidity)
According to modified Dunkley criteria, serotonin syndrome can be diagnosed if a patient has taken a serotonergic drug within 5 weeks and demonstrates tremor with hyperreflexia, among other specific combinations 2.
Clonus and hyperreflexia together are considered highly diagnostic for serotonin syndrome in the setting of serotonergic drug exposure 2.
Medications Associated with Hyperreflexia
Serotonergic medications that can trigger hyperreflexia include 3, 4:
- SSRIs, SNRIs, TCAs, MAOIs
- Opioids (tramadol, meperidine, methadone, fentanyl)
- Stimulants
- Dextromethorphan
- Over-the-counter supplements (St. John's wort, L-tryptophan)
Spinal Cord Injury
In spinal cord injury contexts, hyperreflexia develops through proprioceptive afferent circuit changes and altered GABAergic inhibitory regulation, not through increased motor neuron excitability as previously thought 5.
Clinical Examination
Hyperreflexia is detected by:
- Testing deep tendon reflexes (patellar, Achilles, biceps, triceps)
- Observing exaggerated responses with minimal stimulus
- Checking for associated findings: clonus (rhythmic oscillations with sustained stretch), Babinski sign (upgoing toe)
- Assessing for reflex spread to adjacent muscle groups
Critical Pitfall
Do not assume hyperreflexia always indicates upper motor neuron disease. In Guillain-Barré syndrome, hyperreflexia can occur despite being a peripheral nerve disorder, particularly in patients with antecedent diarrhea and acute motor axonal neuropathy subtype 6. This represents an important exception where hyperreflexia should not delay GBS diagnosis or treatment.
Clinical Significance
The presence of hyperreflexia requires immediate assessment of:
- Recent medication additions (especially serotonergic agents within 5 weeks)
- Associated symptoms (fever, altered mental status, autonomic instability suggesting serotonin syndrome)
- Neurological examination for upper motor neuron signs
- Underlying conditions (liver disease, spinal cord pathology)
In serotonin syndrome with hyperreflexia, mortality approaches 11% 2, making rapid recognition and treatment essential through discontinuation of offending agents and supportive care.